1 year ago
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for GSK in a race against drugmakers Pfizer and Moderna to bring to market a shot that targets the respiratory syncytial virus.
Continue Reading
https://www.cnbc.com
Join the Discussion